BNP Paribas Funds Health Care Innovators Classic Distribution
MVD-Fonds Rating | EDA |
---|---|
79 |
ISIN: LU0823416929 | WKN: A1T8XJ
KAG: BNP PARIBAS AM (LU)
NAV: 1.084,75 EUR am 26.09.2024
Chart
Kennzahlen BNP Paribas Funds Health Care Innovators Classic Distribution
1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
Performance | -4,14% | +3,01% | +15,09% | +19,58% | +66,29% | +122,38% | +332,11% |
Volatilität | +11,43% | +12,42% | +12,96% | +15,21% | +17,41% | +17,60% | +17,17% |
Sharpe Ratio | -3,72 | +0,22 | +0,91 | +0,18 | +0,42 | +0,28 | +0,15 |
Bester Monat | - | +3,26% | +6,33% | +7,56% | +11,93% | +11,93% | +11,93% |
Schl. Monat | - | -5,65% | -5,65% | -7,36% | -7,36% | -12,72% | -12,72% |
Max. Verlust | -5,98% | -5,98% | -8,64% | -15,69% | -25,80% | -32,66% | -60,33% |
Monatsperformance BNP Paribas Funds Health Care Innovators Classic Distribution
2024 | 2023 | 2022 | 2021 | 2020 | |
Januar | +4,70% | -1,59% | -7,36% | +2,13% | +0,39% |
Februar | +2,84% | -1,69% | +0,53% | -1,54% | -4,96% |
März | +2,74% | +0,41% | +5,78% | +3,67% | -2,71% |
April | -1,61% | +1,93% | -0,56% | +0,56% | +11,93% |
Mai | +1,01% | +0,17% | -3,25% | -1,13% | +4,43% |
Juni | +3,26% | -0,20% | +2,67% | +6,27% | -1,60% |
Juli | +2,72% | -0,58% | +7,56% | +1,64% | -2,76% |
August | +2,27% | +0,53% | -2,45% | +2,61% | +1,31% |
September | -5,65% | -1,54% | -2,02% | -2,06% | +0,93% |
Oktober | - | -5,46% | +4,60% | +4,85% | -4,22% |
November | - | +2,42% | +1,78% | -5,07% | +5,49% |
Dezember | - | +6,33% | -5,08% | +6,11% | +2,07% |
Gesamt | +12,52% | +0,29% | +1,09% | +18,83% | +9,48% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (BNP Paribas Funds Health Care Innovators) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche FondsZuletzt angesehen
HSBC GLOBAL INVESTMENT FUNDS - FRONTIER MARKETS | Aktien Emerging Markets | HSBC Inv. Funds (LU) |
ODDO BHF Métropole Small Cap Value | Aktien Europa | ODDO BHF AM SAS |